| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |